Mometasone Teva (Mometasone Furoate)

Mometasone furoate, the active ingredient in Mometasone Teva, is a corticosteroid presented as a 0.1% cream for topical use. It treats inflammatory skin conditions such as eczema, psoriasis, and dermatitis in adults and children.

GNH USA supplies Mometasone Teva as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Mometasone furoate is a potent topical corticosteroid used to manage inflammatory skin disorders.

- Atopic dermatitis: reduces redness, itching and swelling in eczema patients. - Psoriasis: diminishes plaque formation and scaling. - Allergic contact dermatitis: alleviates inflammation caused by allergen exposure.

Topical application of mometasone furoate can be associated with a range of local and systemic reactions.

Common Side Effects: - Burning or stinging sensation at the application site. - Pruritus or mild itching. - Dryness or flaking of the skin. - Folliculitis or acne‑like eruptions. - Mild erythema or irritation. - Telangiectasia (small visible blood vessels).

Serious or Rare Side Effects: - Skin atrophy or thinning. - Hypopigmentation or depigmentation. - Secondary bacterial, fungal or viral infections. - Systemic adrenal suppression with extensive use. - Cushingoid appearance (weight gain, moon face). - Severe allergic reaction (urticaria, angioedema).

When using Mometasone Teva, follow these safety measures to minimize risks.

- Limited area: Apply only to small skin areas and avoid prolonged continuous use. - Occlusion: Do not cover treated skin with airtight dressings unless directed by a physician. - Infections: Avoid use on viral, fungal, or bacterial skin infections without medical supervision. - Children: Use with caution in pediatric patients; monitor for growth suppression. - Systemic steroids: Do not combine with systemic corticosteroids without professional guidance. - Store below 25°C: Keep in the original container, protect from moisture and direct sunlight.

Mometasone furoate may interact with other medications that influence corticosteroid metabolism or increase systemic exposure.

Major Interactions (Avoid): - Systemic corticosteroids: concurrent use can amplify systemic steroid effects and adrenal suppression. - Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): may increase systemic absorption of mometasone.

Moderate Interactions (Monitor Closely): - Topical immunosuppressants (e.g., tacrolimus, pimecrolimus): combined use may heighten local immunosuppression. - Antiviral agents (e.g., acyclovir): monitor for delayed wound healing. - Antifungal creams: assess for additive irritation. - Non‑steroidal anti‑inflammatory drugs (NSAIDs): watch for systemic steroid‑related side effects if absorbed.